Dr Yeh Chen Lee (MBBS BMedSci MPhil[H1] FRACP) is a clinical investigator and medical oncologist with subspecialty expertise in gynaecological cancers and soft tissue sarcoma. Dr Lee is a Staff Specialist at the Prince of Wales – Royal Hospital for Women and Chris O'Brien Lifehouse; and a Research Fellow at the NHMRC Clinical Trials Centre (CTC), University of Sydney.

Following completion of advanced training in medical oncology, Dr Lee pursued a dual research fellowship at Peter MacCallum Cancer Centre (Melbourne, Australia; 2015-2016) and at Princess Margaret Cancer Centre (Toronto, Canada; 2016-2018) in Gynaecology and Drug Development. Dr Lee was awarded first class honours for Master of Philosophy (University of Melbourne) investigating ways to improve ovarian cancer care along the disease trajectory.

Dr Lee’s research focus is to improve patient care in gynaecological cancers and soft tissue sarcoma, through advancing and translating knowledge in cancer genetics, drug development and supportive care. Her research accomplishments included receipt of the GCIG Scholar Award (2019), CAHON Young Investigator Award (2018), Tannock Fellowship Award (2017) and Conquer Cancer Foundation of ASCO Merit Award (2016). Dr Lee’s research leadership includes as appointed chair of the NGOR (National Gynae-Oncology Registry) rare cancer group; member of committees of ANZGOG (Australia New Zealand Gynaecological Oncology Group); member of scientific advisory committee of ANZSA (Australia New Zealand Sarcoma Association); and member of Reference Committee for EviQ Cancer Treatment Online. Dr Lee is highly active in clinical trials in cancers and has been involved in the conduct of >50 Phase I-III investigator-initiated and collaborative trials.

Dr Lee’s qualifications and publications can be found here.